{"nct_id":"NCT03729245","title":"A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC)","status":"TERMINATED","status_verified_date":"2023-03","start_date":"2018-12-18","start_date_type":"ACTUAL","primary_completion_date":"2022-01-07","primary_completion_date_type":"ACTUAL","completion_date":"2022-10-19","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NKTR"]}